Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

medicines use

- PMLiVE

Neurodegenerative disorders market set to reach $45bn by 2022

But shake-up expected from flurry of new approvals and patent expirations

- PMLiVE

Global drug spending will rise by a third to $1.5trn in 2021

However, rate of growth will not match previous years due to pricing and access pressures

- PMLiVE

IMS Health and Quintiles complete merger

Launch global healthcare information and technology specialist QuintilesIMS

- PMLiVE

Transformational technology

Big data, the cloud and the value of insights

- PMLiVE

Global pharma market forecast to reach $1.12tr by 2022

Annual growth of 6.3 per cent expected and biologics are set to occupy a stronger position

- PMLiVE

Multichannel: the essential European revolution

Boosting the digital component in Europe's multichannel engagement strategy

- PMLiVE

Diabetes treatment ‘inextricably’ linked to patient education

Condition remains a significant burden for health systems

EU flag

European pharma ‘to grow 3.2% per year by 2022’

Forecast predicts AbbVie’s Humira will be knocked off the top spot

- PMLiVE

The Digital Patient

Earlier this year, the European Commission published a broad-ranging plan to digitise EU industries to help usher in what has become known as the fourth industrial revolution.

- PMLiVE

Reaching new heights

Global medicines use and a five-year forecast

China drug medicine pharma prices

Cancer drugs “less affordable in low-income countries”

China and India are among those hit hardest by the rapidly escalating price of therapies

- PMLiVE

Explosive evolution

Companies are being forced to diversify and specialise their business models

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links